Koers Dynavax Technologies Corporation Nasdaq
Aandelen
US2681581029
Biotechnologie & Medisch Onderzoek
slotkoers
Andere beurzen
|
||
- USD | - |
Omzet 2024 * | 285 mln. 266 mln. | Omzet 2025 * | 349 mln. 326 mln. | Marktkapitalisatie | 1,51 mld. 1,41 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 18 mln. 16,82 mln. | Nettowinst (verlies) 2025 * | 47 mln. 43,91 mln. | EV/omzet 2024 * | 3,36 x |
Nettoliquiditeiten 2024 * | 556 mln. 519 mln. | Nettoliquiditeiten 2025 * | 683 mln. 638 mln. | EV/omzet 2025 * | 2,38 x |
K/w-verhouding 2024 * |
72,2
x | K/w-verhouding 2025 * |
32,8
x | Werknemers | - |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 99,66% |
Recentste transcriptie over Dynavax Technologies Corporation
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Ryan Spencer
CEO | Chief Executive Officer | 46 | 01-01-05 |
David Novack
PSD | President | 62 | 25-03-13 |
Patricia Novy
CTO | Chief Tech/Sci/R&D Officer | - | 01-01-21 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Francis Cano
BRD | Director/Board Member | 79 | 03-11-09 |
Peggy Phillips
BRD | Director/Board Member | 70 | 01-08-06 |
Dan Kisner
BRD | Director/Board Member | 77 | 22-07-10 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+18,15% | 124 mld. | |
+18,02% | 112 mld. | |
+5,07% | 22,94 mld. | |
-12,75% | 22,22 mld. | |
-9,86% | 17,02 mld. | |
-14,97% | 16,88 mld. | |
-39,94% | 16,87 mld. | |
+2,80% | 13,63 mld. | |
+27,39% | 11,61 mld. |
- Beurs
- Aandelen
- Koers DVAX
- Koers